Medicare Enrolled
Dr. Basil Burney, M.D
Endocrinology · Colleyville, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Burney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Burney?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Burney
Dr. Basil Burney is an endocrinology specialist in Colleyville, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Burney performed 873 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Burney received a total of $891,826 from 60 pharmaceutical and/or device companies across 2231 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Burney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 46% volume in TX
$891,826 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗873
Medicare services
Top 46% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
312 | $90 | $235 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
235 | $3 | $19 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $115 | $358 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
85 | $10 | $66 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
51 | $24 | $100 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
44 | $79 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $64 | $158 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
13 | $107 | $425 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $80 | $235 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$891,826
Total received (2018-2024)
Avg $127,404/year across 7 years
Top 2% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
2,231
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$109,612
2023
$151,961
2022
$171,651
2021
$96,159
2020
$75,280
2019
$131,476
2018
$155,686
Payments by company (2024)
Lilly USA, LLC
$51,563
Boehringer Ingelheim Pharmaceuticals, Inc.
$29,592
Novo Nordisk Inc
$26,407
Amgen Inc.
$302
Abbott Laboratories
$207
Insulet Corporation
$167
Xeris Pharmaceuticals, Inc.
$143
IBSA Pharma Inc.
$111
ABBVIE INC.
$105
Dexcom, Inc.
$101
Antares Pharma, Inc.
$93
Amneal Pharmaceuticals LLC
$86
Bayer Healthcare Pharmaceuticals Inc.
$76
BETA BIONICS, INC.
$75
Tandem Diabetes Care, Inc.
$64
Acella Pharmaceuticals, LLC
$59
Medtronic, Inc.
$56
CeQur Corporation
$50
Nevro Corp.
$48
Corcept Therapeutics
$37
Alexion Pharmaceuticals, Inc.
$35
Neurocrine Biosciences, Inc.
$34
VIVUS LLC
$32
RECORDATI_RARE_DISEASES_INC.
$31
Astellas Pharma US Inc
$29
SANOFI-AVENTIS U.S. LLC
$28
Kyowa Kirin, Inc.
$26
Chiesi USA, Inc.
$25
Currax Pharmaceuticals LLC
$16
Avvisto Therapeutics, LLC
$15
Top 3 companies account for 98.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$342,226
Lilly USA, LLC
$272,614
Boehringer Ingelheim Pharmaceuticals, Inc.
$129,886
Janssen Pharmaceuticals, Inc
$75,664
Amgen Inc.
$22,685
Dexcom, Inc.
$14,487
Bayer HealthCare Pharmaceuticals Inc.
$12,997
Bayer Healthcare Pharmaceuticals Inc.
$7,810
Corcept Therapeutics
$2,941
DEXCOM, INC.
$2,040
AstraZeneca Pharmaceuticals LP
$1,354
SANOFI-AVENTIS U.S. LLC
$930
Abbott Laboratories
$891
Amarin Pharma Inc.
$619
Insulet Corporation
$426
RECORDATI_RARE_DISEASES_INC.
$296
IBSA Pharma Inc.
$257
Medtronic MiniMed, Inc.
$256
Antares Pharma, Inc.
$252
MannKind Corporation
$199
Xeris Pharmaceuticals, Inc.
$193
Merck Sharp & Dohme Corporation
$175
Alexion Pharmaceuticals, Inc.
$174
Tandem Diabetes Care, Inc.
$168
ABBVIE INC.
$165
AbbVie Inc.
$153
CeQur Corporation
$147
Mannkind Corporation
$143
Horizon Therapeutics plc
$128
Medtronic, Inc.
$127
VIVUS, Inc.
$124
Amneal Pharmaceuticals LLC
$122
Acella Pharmaceuticals, LLC
$108
PFIZER INC.
$96
Nevro Corp.
$94
Kowa Pharmaceuticals America, Inc.
$94
Shire North American Group Inc
$90
BETA BIONICS, INC.
$75
EISAI INC.
$65
VIVUS LLC
$63
Rhythm Pharmaceuticals, Inc.
$54
Supernus Pharmaceuticals, Inc.
$43
Radius Health, Inc.
$35
Neurocrine Biosciences, Inc.
$34
Eisai Inc.
$31
Astellas Pharma US Inc
$29
Kyowa Kirin, Inc.
$26
Chiesi USA, Inc.
$25
Alvogen Inc
$21
Novartis Pharmaceuticals Corporation
$20
Regeneron Healthcare Solutions, Inc.
$20
LifeScan, Inc.
$20
Esperion Therapeutics, Inc.
$19
Intuity Medical Inc
$18
Ultragenyx Pharmaceutical Inc.
$18
Amryt Pharma Holdings Ltd
$17
Amphastar Pharmaceuticals, Inc.
$17
Currax Pharmaceuticals LLC
$16
Avvisto Therapeutics, LLC
$15
Senseonics, Incorporated
$9
Top 3 companies account for 83.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · Belviq · CHANTIX · CONTRAVE · CYCLOSET · CYRAMZA · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DISEASE STATE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LYUMJEV · Lenvima · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Norditropin · NovoLog · OTREXUP · Omnipod · OneTouch · Ozempic · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Senza · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
108
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
SAINT CAMILLUS MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Burney is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Burney experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Burney performed 312 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Burney receive payments from pharmaceutical companies?
Yes. Dr. Burney received a total of $891,826 from 60 companies across 2,231 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Burney's costs compare to other endocrinologists in Colleyville?
Dr. Burney's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Burney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Colleyville
Browse endocrinologists in Colleyville ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in TX
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in TX
Which TX endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology